Investing.com - Ibio reported on Tuesday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Ibio announced earnings per share of $-0.0700 on revenue of $200K. Analysts polled by Investing.com anticipated EPS of $-0.0650 on revenue of $250K.
Ibio shares are down 13% from the beginning of the year, still down 72.04% from its 52 week high of $1.13 set on September 29, 2021.
Ibio follows other major Healthcare sector earnings this month
Ibio's report follows an earnings beat by Merck ADR on September 9, who reported EPS of $0.5392 on revenue of $5.69B, compared to forecasts EPS of $0.5165 on revenue of $5.57B.
Veeva Systems A had beat expectations on August 31 with second quarter EPS of $1.03 on revenue of $534.22M, compared to forecast for EPS of $1.01 on revenue of $530.71M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar